✦ LIBER ✦

Retrospective study of efficacy and toxicity on patients older than 70 years within a randomized clinical trial of two cisplatin-based combinations in patients with small-cell lung cancer

✍ Scribed by Safont, María José; Artal-Cortes, Ángel; Sirera, Rafael; Gómez-Codina, José; González-Larriba, José Luis; Barneto, Isidoro; Carrato, Alfredo; Isla, Dolores; Rosell, Rafael; Camps, Carlos

Book ID: 119319942
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 295 KB
Volume: 63
Category: Article
ISSN: 0169-5002
DOI: 10.1016/j.lungcan.2008.04.015

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I and pharmacokinetic study of d

A phase I and pharmacokinetic study of daily oral cediranib, an inhibitor of vascular endothelial growth factor tyrosine kinases, in combination with cisplatin and gemcitabine in patients with advanced non-small cell lung cancer: A study of the National Cancer Institute of Canada Clinical Trials Group

✍ Glenwood Goss; Frances A. Shepherd; Scott Laurie; Isabelle Gauthier; N. Leighl; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 137 KB

A phase II study of induction chemothera

A phase II study of induction chemotherapy (Ind CT) with CPT-11 and cisplatin followed by thoracic radiation (TRT) combined with weekly CPT-11 in patients with unresectable stage III non-small-cell lung cancer (NSCLC): A Japan Clinical Oncology (JCOG) 9706 Trial

✍ Takifuji, N; Negoro, S; Fukuoka, M; Kawahara, M; Ishizuka, N; Saijo, N; Shimoyam 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 114 KB